Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | GAA | P10253 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | ACR | P10323 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5842867 | 0.83 | LMNA (0.56) | LMNAGAAKMT2AL3MBTL1TDP1 | |
| SCHEMBL645265 | 0.83 | KMT2A (0.69) | LMNAGAAKMT2AL3MBTL1TDP1 | |
| SCHEMBL241601 | 0.83 | LMNA (0.61) | LMNAGAAKMT2AL3MBTL1TDP1 | |
| SCHEMBL10907507 | 0.82 | LMNA (0.61) | LMNAGAAKMT2AL3MBTL1TDP1 | |
| SCHEMBL11151702 | 0.81 | KMT2A (0.45) | LMNAGAAKMT2ATDP1ALDH1A1 | |
| SCHEMBL561023 | 0.81 | KMT2A (0.45) | LMNAGAAKMT2ATDP1ALDH1A1 | |
| SCHEMBL11773507 | 0.81 | KMT2A (0.45) | LMNAGAAKMT2AALDH1A1MAPT | |
| SCHEMBL28183303 | 0.81 | LMNA (0.59) | LMNAGAAKMT2AL3MBTL1TDP1 | |
| SCHEMBL2239096 | 0.81 | KMT2A (0.66) | LMNAGAAKMT2AL3MBTL1TDP1 | |
| SCHEMBL10593101 | 0.80 | KMT2A (0.57) | LMNAGAAKMT2AL3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4659751-A | Simplified method for obtained strong adhesive bonding of composites to dentin, enamel and other substrates | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1987-04-21 | — | — | US | claimed |
| JP-1144487-A | — | — | None | — | — | JP | disclosed |
| US-20240399776-A1 | COLOR DEVELOPER, THERMAL RECORDING MATERIAL, AND THERMAL RECORDING LAYER COATING MATERIAL | SANKO CO., LTD. (JP) | 2024-12-05 | — | — | US | disclosed |
| EP-4269119-A1 | COLOR DEVELOPER, HEAT-SENSITIVE RECORDING MATERIAL, AND COATING MATERIAL FOR HEAT-SENSITIVE RECORDING LAYERS | Sanko Co., Ltd. (JP) | 2023-11-01 | — | — | EP | disclosed |
| CN-113004162-B | Preparation method of asymmetric gem diaryl acetate compound | 苏州大学 | 2023-05-05 | — | — | CN | disclosed |
| CN-115989341-A | Method for manufacturing structure with conductive pattern | 旭化成株式会社 | 2023-04-18 | — | — | CN | disclosed |
| WO-2022145400-A1 | COLOR DEVELOPER, HEAT-SENSITIVE RECORDING MATERIAL, AND COATING MATERIAL FOR HEAT-SENSITIVE RECORDING LAYERS | 三光株式会社 | 2022-07-07 | — | — | WO | disclosed |
| WO-2022098371-A1 | PRODRUGS OF 1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGUES FOR ANTIVIRAL TREATMENT | YAN MATTHEW (US) | 2022-05-12 | — | — | WO | disclosed |
| WO-2021142244-A1 | SKIN TREATMENT METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF ACTIVE AGENTS | TOPIX PHARMACEUTICALS, INC. (US) | 2021-07-15 | — | — | WO | disclosed |
| CN-113004162-A | Preparation method of asymmetric geminal diaryl acetate compound | 苏州大学 | 2021-06-22 | — | — | CN | disclosed |
| US-20150257986-A1 | ENZYMATICALLY AND HYDROLYTICALLY STABLE RESINS, RESIN MONOMERS, AND RESIN COMPOSITES FOR USE IN DENTAL PREVENTIVE AND RESTORATIVE APPLICATIONS | ADA FOUNDATION | 2015-09-17 | — | — | US | disclosed |
| EP-2563324-A1 | COSMETIC COMPOSITION CONTAINING OLIGOPEPTIDES | Cognis IP Management GmbH (DE) | 2013-03-06 | — | — | EP | disclosed |
| WO-2011134568-A1 | COSMETIC COMPOSITION CONTAINING OLIGOPEPTIDES | COGNIS IP MANAGEMENT GMBH (DE) | 2011-11-03 | — | — | WO | disclosed |
| CN-102093363-A | Pyrrolo-triazine aniline compounds useful as kinase inhibitors | BRISTOL MYERS SQUIBB CO | 2011-06-15 | — | — | CN | disclosed |
| CN-1662509-A | Pyrrolotriazine aniline compounds useful as kinase inhibitors | BRISTOL MYERS SQUIBB CO (US) | 2005-08-31 | — | — | CN | disclosed |
| CN-1135333-A | Usage of SRCSH2 specific compound for treatment of bone absorption disease | SMITHKLINE BEECHAM CORP (US) | 1996-11-13 | — | — | CN | disclosed |
| JP-H01144487-A | PRODUCT FOR MANUFACTURING SURFACE OF SUBSTRATE | DEN MAT CORP | 1989-06-06 | — | — | JP | disclosed |
| US-4588756-A | Multi-step method for obtaining strong adhesive bonding of composites to dentin, enamel and other substrates | AMERICAN DENTAL ASSOCIATION HEALTH FOUNDATION (US) | 1986-05-13 | — | — | US | disclosed |
| US-4088657-A | FROM AN ALIPHATIC NITRILE AND GLYCOLIC ACID IN SULFURIC ACID, CONDENSING WITH AN AROMATIC HYDROCARBON OR THIOPHENE | NOBEL HOECHST CHIMIE (FR) | 1978-05-09 | — | — | US | disclosed |
| US-RE29213-E | TRIMELLITIC ANHYDRIDE, DIISOCYANATE, GLYCINE DERIVATIVE | SCHENECTADY CHEMICALS, INC. (US) | 1977-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150257986-A1 | ENZYMATICALLY AND HYDROLYTICALLY STABLE RESINS, RESIN MONOMERS, AND RESIN COMPOSITES FOR USE IN DENTAL PREVENTIVE AND RESTORATIVE APPLICATIONS | ESD, JMJD6, DNPH1 | LMNA 1826/4885GAA 157/4885KMT2A 929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.